Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xoma Royalty Depository Shares Series B XOMAO

Healthcare Biotechnology
XOMA Royalty Corporation, formerly XOMA Corporation, is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments... see more

Recent & Breaking News (NDAQ:XOMAO)

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

GlobeNewswire January 8, 2024

XOMA Announces Stock Repurchase Program of up to $50 Million

GlobeNewswire January 2, 2024

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire December 20, 2023

XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties

GlobeNewswire December 19, 2023

XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value

GlobeNewswire November 7, 2023

XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One's Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

GlobeNewswire October 31, 2023

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire September 25, 2023

XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 6, 2023

XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy

GlobeNewswire August 8, 2023

XOMA Added to the Russell 2000® and Russell 3000® Indexes

GlobeNewswire June 23, 2023

XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset

GlobeNewswire June 22, 2023

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire June 20, 2023

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

GlobeNewswire May 9, 2023

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire March 21, 2023

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

GlobeNewswire March 9, 2023

XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events

GlobeNewswire November 3, 2022

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire September 21, 2022

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire June 20, 2022

XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events

GlobeNewswire May 5, 2022

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire March 21, 2022